Serum neuron-specific enolase is correlated with clinical outcome of patients with non-germinal center B cell-like subtype of diffuse large B-cell lymphoma treated with rituximab-based immunochemotherapy. [electronic resource]
Producer: 20130614Description: 2153-8 p. digitalISSN:- 1559-131X
- Adult
- Aged
- Antibodies, Monoclonal, Murine-Derived -- therapeutic use
- Antineoplastic Combined Chemotherapy Protocols -- therapeutic use
- Biomarkers, Tumor -- blood
- Cyclophosphamide
- Doxorubicin
- Female
- Humans
- Immunohistochemistry
- Immunotherapy
- Kaplan-Meier Estimate
- Luminescent Measurements
- Lymphoma, Large B-Cell, Diffuse -- blood
- Male
- Middle Aged
- Neoplasm Staging
- Phosphopyruvate Hydratase -- blood
- Prednisone
- Prognosis
- Proportional Hazards Models
- Rituximab
- Treatment Outcome
- Vincristine
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.